Effects of polymyxin B hemoperfusion on mortality in patients with severe sepsis and septic shock: A systemic review, meta-analysis update, and disease severity subgroup meta-analysis

Critical Care Medicine

Volumn 45, Issue 8, 2017, Pages e858-e864

  Chang, Tzu ^a   Tu, Yu Kang ^b   Lee, Chen Tse ^a   Chao, Anne ^a   Huang, Chi Hsiang ^a   Wang, Ming Jiuh ^a   Yeh, Yu Chang ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

endotoxin; hemoperfusion; mortality; polymyxin B; sepsis

Indexed keywords

CYTOKINE; ENDOTOXIN; POLYMYXIN B; ANTIINFECTIVE AGENT;

ANTIBIOTIC THERAPY; DISEASE SEVERITY; DRUG EFFECT; EXTRACORPOREAL OXYGENATION; HEMODYNAMICS; HEMOPERFUSION; HIGH RISK POPULATION; HUMAN; LOW RISK POPULATION; META ANALYSIS; MORTALITY RATE; MORTALITY RISK; OXYGENATION; PRIORITY JOURNAL; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK REDUCTION; SEPSIS; SEPTIC SHOCK; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SYSTEMATIC REVIEW; BLOOD; BLOOD PRESSURE; MORTALITY; ORGAN DYSFUNCTION SCORE; PROCEDURES; SEVERITY OF ILLNESS INDEX; SHOCK, SEPTIC;

ANTI-BACTERIAL AGENTS; BLOOD PRESSURE; ENDOTOXINS; HEMOPERFUSION; HUMANS; ORGAN DYSFUNCTION SCORES; POLYMYXIN B; SEPSIS; SEVERITY OF ILLNESS INDEX; SHOCK, SEPTIC;

EID: 85021634263     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000002362     Document Type: Review

References (28)

1. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20:864-874
2. Heumann D, Glauser MP, Calandra T: Molecular basis of host-pathogen interaction in septic shock. Curr Opin Microbiol 1998; 1:49-55
3. Danner RL, Elin RJ, Hosseini JM, et al: Endotoxemia in human septic shock. Chest 1991; 99:169-175
4. Davies B, Cohen J: Endotoxin removal devices for the treatment of sepsis and septic shock. Lancet Infect Dis 2011; 11:65-71
5. Hanasawa K, Tani T, Oka T, et al: Selective removal of endotoxin from the blood by extracorporeal hemoperfusion with polymyxin B immobilized fiber. Prog Clin Biol Res 1988; 264:337-341
6. Nemoto H, Nakamoto H, Okada H, et al: Newly developed immobilized polymyxin B fibers improve the survival of patients with sepsis. Blood Purif 2001; 19:361-368
7. Cruz DN, Antonelli M, Fumagalli R, et al: Early use of polymyxin B hemoperfusion in abdominal septic shock: The EUPHAS randomized controlled trial. JAMA 2009; 301:2445-2452
8. Mitaka C, Tomita M: Polymyxin B-immobilized fiber column hemoperfusion therapy for septic shock. Shock 2011; 36:332-338
9. Iwagami M, Yasunaga H, Doi K, et al: Postoperative polymyxin B hemoperfusion and mortality in patients with abdominal septic shock: A propensity-matched analysis. Crit Care Med 2014; 42:1187-1193
10. Payen DM, Guilhot J, Launey Y, et al; ABDOMIX Group: Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: A multicenter randomized control trial. Intensive Care Med 2015; 41:975-984
11. Sterne JAC, Higgins JPT, Reeves BC, et al: A Tool for Assessing Risk Of Bias in Non-Randomized Studies of Interventions, Version 7 March 2016. Available at http://www.riskofbias.info. Accessed August 28, 2016
12. Maynar J, Martínez-Sagasti F, Herrera-Gutiérrez M, et al: Direct hemoperfusion with polymyxin B-immobilized cartridge in severe sepsis due to intestinal perforation: Hemodynamic findings and clinical considerations in anticoagulation therapy. Rev Esp Quimioter 2013; 26:151-158
13. Suzuki H, Nemoto H, Nakamoto H, et al: Continuous hemodiafiltration with polymyxin-B immobilized fiber is effective in patients with sepsis syndrome and acute renal failure. Ther Apher 2002; 6:234-240
14. Javeri Y, Madaan A, Juneja D, et al: Study of the role of polymyxin B direct hemoperfusion as an adjuvant therapy in severe sepsis of varied etiology. Intensive Care Med 2011; 37:S41
15. Sawa N, Ubara Y, Sumida K, et al: Direct hemoperfusion with a polymyxin B column versus vasopressin for gram negative septic shock: A matched cohort study of the effect on survival. Clin Nephrol 2013; 79:463-470
16. Takahashi M, Takeuchi H, Kawakubo H, et al: Effectiveness of polymyxin B-direct hemoperfusion (PMX-DHP) therapy using a polymyxin B-immobilized fiber column in patients with post-esophagectomy sepsis. Esophagus 2014; 11:189-196
17. Saito N, Sugiyama K, Ohnuma T, et al: Effectiveness of polymyxin B immobilized fiber hemoperfusion in patients with septic shock due to Gram-negative bacillus infection: The PMXHP study. Critical Care 2015; 19:S45
18. Nakamura Y, Kiyomi F, Hoshino K, et al: The efficacy of the polimyxin B immobilized fiber column direct hemoperfusion for septic shock. Crit Care Med 2015; 43:266
19. Srinivasan T, Singh MK, Goja S, et al: Toraymyxin filtration in septic shock in living donor liver transplantation-significant improvement in outcome when used at the right time and the right patient. Transplantation 2015; 99:282
20. Tani T, Hanasawa K, Endo Y, et al: Therapeutic apheresis for septic patients with organ dysfunction: Hemoperfusion using a polymyxin B immobilized column. Artif Organs 1998; 22:1038-1044
21. Nakamura T, Ushiyama C, Suzuki S, et al: Polymyxin b-immobilized fiber reduces increased plasma endothelin-1 concentrations in hemodialysis patients with sepsis. Ren Fail 2000; 22:225-234
22. Vincent JL, Laterre PF, Cohen J, et al: A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infection. Shock 2005; 23:400-405
23. Nakamura T, Kawagoe Y, Suzuki T, et al: Changes in plasma interleukin-18 by direct hemoperfusion with polymyxin B-immobilized fiber in patients with septic shock. Blood Purif 2005; 23:417-420
24. Iwagami M, Yasunaga H, Noiri E, et al: Potential survival benefit of polymyxin B hemoperfusion in septic shock patients on continuous renal replacement therapy: A propensity-matched analysis. Blood Purif 2016; 42:9-17
25. Takeyama N, Noguchi H, Hirakawa A, et al; Japan Sepsis Study Group: Time to initiation of treatment with polymyxin B cartridge hemoperfusion in septic shock patients. Blood Purif 2012; 33:252-256
26. Klein CL, Hoke TS, Fang WF, et al: Interleukin-6 mediates lung injury following ischemic acute kidney injury or bilateral nephrectomy. Kidney Int 2008; 74:901-909
27. Doi K, Leelahavanichkul A, Hu X, et al: Pre-existing renal disease promotes sepsis-induced acute kidney injury and worsens outcome. Kidney Int 2008; 74:1017-1025
28. Hoke TS, Douglas IS, Klein CL, et al: Acute renal failure after bilateral nephrectomy is associated with cytokine-mediated pulmonary injury. J Am Soc Nephrol 2007; 18:155-164